GSK

2024 top biotech and pharma employers survey by Science magazine identifies leading companies in the industry

Positive mid-stage trial results push GSK's mRNA flu vaccine towards late-stage clinical development, showing enhanced immune…

GSK’s experimental herpes vaccine misses trial target, but study continues for safety monitoring and insights into recurrent…

GSK will take control of CureVac's leading experimental vaccines to fight infections, including seasonal flu and bird flu

Pharmaceutical manufacturers like Boehringer Ingelheim, GSK, and AstraZeneca are participating in this initiative

The RSV vaccine adjuvanted is currently approved for use in adults aged 60 and older and recommended by CDC/ACIP using shared…

The final trial data demonstrate that Shingrix maintains efficacy against shingles for more than a decade in adults over 50

GSK is also in the process of developing a pentavalent vaccine, and positive Phase III data were announced earlier this year.…

Profit After Tax (PAT) for the quarter at Rs 131 crores grew by ~ 13 per cent

GSK’s latest campaign film highlights the painful disease and its risk in adults above the age of 50 and the possibility of…